Trial Profile
Fondaparinux as monotherapy for deep vein thrombosis and/or pulmonary embolism (pilot study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2023
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism
- Focus Therapeutic Use
- 09 Jan 2007 New trial record.